Aurobindo Pharma recalls 47,040 bottles of Venlafaxine Hydrochloride capsules in US

23 Feb 2017 Evaluate

Aurobindo Pharma’s US arm is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules, manufactured by the Hyderabad-based firm, from the American market. Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder.

Aurobindo Pharma USA Inc is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules in the strength of 37.5 mg in a nationwide recall in the US. As per the United States Food and Drug Administration (USFDA) the recall is on account of failed tablet/capsule specifications: some bottles contain punctured, and/or clumped /melted capsules.

The voluntary ongoing recall is a Class II recall. According the FDA, a class II recall is initiated in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.


Aurobindo Pharma Share Price

1209.00 -17.15 (-1.40%)
04-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1704.00
Dr. Reddys Lab 1237.15
Cipla 1325.55
Zydus Lifesciences 905.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×